Article

Comparison of three instruments for measuring red blood cell aggregation

Department of Physiology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Clinical hemorheology and microcirculation (Impact Factor: 2.22). 01/2009; 43(4):283-98. DOI: 10.3233/CH-2009-1240
Source: PubMed

ABSTRACT The International Society for Clinical Hemorheology organized a workshop to compare three instruments for measuring RBC aggregation: LORCA, Myrenne Aggregometer and RheoScan-A. The Myrenne Aggregometer provides indices at stasis (M) and at low shear (M1), with four indices obtained with the LORCA and RheoScan-A: amplitude (AMP), half-time (T1/2), surface area (SA) above (LORCA) or below (RheoScan-A) the syllectogram, and the ratio (AI) of the area above (LORCA) or below (RheoScan-A) the syllectogram to total area (AI). Intra-assay reproducibility and biological variability were determined; also studied were RBC in diluted plasma and in 1% 500 kDa dextran, and 0.003% glutaradehyde (GA)-treated cells in plasma. All measurements were performed at 37 degrees C. Standardized difference values were used as a measure of power to detect differences. Salient results were: (1) intra-assay variations below 5% except for RheoScan-A AMP and SA; (2) biological variability greatest for T1/2 with other indices similar for the three devices; (3) all instruments detected progressive changes with plasma dilution; (4) the Myrenne and LORCA, but not the RheoScan-A, detected differences for cells in dextran; (5) GA-treatment significantly affected the LORCA (AMP, T1/2, SA, AI), the RheoScan-A (AMP, SA, AI) and the Myrenne M parameter. It is concluded that: (a) the LORCA, Myrenne and the RheoScan-A have acceptable precision and suitable power for detecting reduced aggregation due to plasma dilution; (b) greatly enhanced RBC aggregation may not be sensed by the RheoScan-A while the Myrenne M1 index may be insensitive to minor increases of cell rigidity; (c) future studies should define each instrument's useful range for detecting RBC aggregation.

Download full-text

Full-text

Available from: Sehyun Shin, Jul 30, 2015
2 Followers
 · 
250 Views
  • Source
    • "In fact, to our knowledge, there is no standard method to provide an estimation of aggregate size for prescribed flow conditions. The existing methods, such as erythrocyte sedimentation rate [7] [8] [9], microscopic aggregation index [10] [11] and syllectometry method [12] [13] are only able to provide several aggregation indices to estimate the degree of aggregation in blood, which does not provide enough information to understand blood behavior in microcirculation. Therefore, a controlled experimental model is required for RBC aggregate analysis and size estimation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: The aim of the work presented in this paper is to design a microfluidic apparatus capable of providing controlled flow conditions suitable for Red Blood Cell (RBC) aggregation analysis. The linear velocity engendered from the controlled flow provides constant shear rates used to qualitatively analyze RBC aggregates. These controlled conditions are created by a two fluid flow where blood is entrained by a second, less viscous fluid. Method of approach: The design of the apparatus is based on numerical and experimental work. The numerical work consists of 3D numerical simulations performed using a research CFD solver, Nek5000, while the experiments are conducted using a micro-particle image velocimetry system. The microchannel used consists of a 150 × 33 ?m PDMS channel fabricated using standard photolithography methods. A Newtonian model is tested numerically and experimentally, then blood is tested experimentally under several conditions (hematocrit, shear rate and fluid suspension) to be compared to the simulation results. Results: We find that using a velocity ratio of 4 between the two Newtonian fluids, the layer corresponding to blood expands to fill 35% of the channel thickness where the constant shear rate is achieved. Conclusions: For blood experiments, the velocity profile in the blood layer is approximately linear, resulting in the desired controlled conditions for the study of RBC aggregation under several flow scenarios. Keywords: Blood, micro-PIV, Non-Newtonian fluid, CFD.
    Journal of Biomechanical Engineering 04/2014; DOI:10.1115/1.4027351 · 1.75 Impact Factor
  • Source
    • "Furthermore, the CSS showed a significantly higher value in patients with decreased myocardial perfusion. Erythrocyte sedimentation rate (ESR) and low-shear blood viscosity are also known to reflect the extent of red cell aggregation [3] [9]. It was demonstrated that ESR showed a similar pattern to that of the CSS. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We sought to investigate the influence of the extent of myocardial injury on left ventricular (LV) systolic and diastolic function in patients after reperfused acute myocardial infarction (AMI). Thirty-eight reperfused AMI patients underwent cardiac magnetic resonance (CMR) imaging after percutaneous coronary revascularization. The extent of myocardial edema and scarring were assessed by T2 weighted imaging and late gadolinium enhancement (LGE) imaging, respectively. Within a day of CMR, echocardiography was done. Using 2D speckle tracking analysis, LV longitudinal, circumferential strain, and twist were measured. Extent of LGE were significantly correlated with LV systolic functional indices such as ejection fraction (r = -0.57, p < 0.001), regional wall motion score index (r = 0.52, p = 0.001), and global longitudinal strain (r = 0.56, p < 0.001). The diastolic functional indices significantly correlated with age (r = -0.64, p < 0.001), LV twist (r = -0.39, p = 0.02), average non-infarcted myocardial circumferential strain (r = -0.52, p = 0.001), and LV end-diastolic wall stress index (r = -0.47, p = 0.003 with e') but not or weakly with extent of LGE. In multivariate analysis, age and non-infarcted myocardial circumferential strain independently correlated with diastolic functional indices rather than extent of injury. In patients with timely reperfused AMI, not only extent of myocardial injury but also age and non-infarcted myocardial function were more significantly related to LV chamber diastolic function.
    Cardiovascular Ultrasound 02/2014; 12(1):6. DOI:10.1186/1476-7120-12-6 · 1.28 Impact Factor
  • Source
    • "RBCA can be reliably measured using various commercially available instruments based on photometric methods [2]. These instruments are primarily designed for use in research laboratories [5] and are not easily applicable in a clinical, non-laboratory environment; most of these instruments require manual cleaning of the parts in contact with blood, thus generating a potentially serious biohazard risk. In contrast , the capillary tube aggregometer described herein has been developed as a point-of-care instrument to estimate disease activity: Its main features include very simple design, easy application, and the ability to provide rapid results using a very small amount of blood sample. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A new method is described in this paper that allows measurement of red blood cell (RBC) aggregation indexes in disposable glass tubes within minutes. Light transmission through the RBC suspension filled into a microhematocrit capillary at stasis is recorded during RBC aggregation; a novel method assures an initial dispersion of aggregates in the capillary. The resulting light transmittance-time data are analyzed to calculate various parameters. Measurement of erythrocyte sedimentation rate (ESR) and RBC aggregation using well established methods and the newly developed capillary tube aggregometer in blood samples with a wide range of RBC aggregation indicated significant correlations between these parameters. Additionally, light transmittance during complete disaggregation allows estimating hematocrit, thereby enabling hematocrit correction of the measured and calculated parameters. The newly developed capillary tube RBC aggregometer is suitable for use as a method to rapidly monitor disease activity and the acute phase response, especially at the point-of-care (e.g., health care facilities, physician's office) and for field studies.
    Clinical hemorheology and microcirculation 01/2011; 47(4):295-305. DOI:10.3233/CH-2011-1411 · 2.22 Impact Factor
Show more